PAROCAINE : Evaluation of the Clinical Tolerance of an Intra-Parotid Injection of Bupivacaine Combined with Dexamethasone After Parotidectomy for a Benign Tumor – Prospective Single-Center Cohort Study

Condition studied

Indication opératoire validée de parotidectomie partielle pour tumeur parotidienne

Investigational medicinal product(s)

Eligibility

Primary endpoint

Collection within 15 days of injection of any local side effects related to the injection of bupivacaine.

Endpoint detail

Pain level (VAS 0-10) on D0, D1, D2, D4, D6, D9, D12, and at the D15 consultation., Collection of data on the occurrence of salivary fistula or clinical sialoma at the post-operative consultation on D15 : yes/no., Administration of a questionnaire on the quality of healing (dehiscence, inflammation, infection) at the 15-day follow-up., Feasibility questionnaire, to be completed by the surgeon on the day of surgery.